Cummings Keith Lamont
SEC insider (Form 3/4/5 filer). CIK 0001809204. Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX). 18 reported Form 4/5 transactions since Sep 2024; latest on Apr 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Cummings Keith Lamont has filed insider reports for
- PLIANT THERAPEUTICS, INC. (PLRX): Officer, Chief Financial Officer
Cummings Keith Lamont
CIK: 0001809204
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PLIANT THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
110.5K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
113.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
113.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
76K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
76K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
18.2K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
18.2K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
74.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
74.3K shares- - Apr 17, 2026PLRX
PLIANT THERAPEUTICS, INC.
DispositionDirectStock Option (Right to Buy)
124K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 110,500 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 113,300 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 113,300 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 76,047 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 76,047 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 18,198 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 18,198 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 74,250 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 74,250 | - | - | Direct |
| Apr 17, 2026 | PLRX PLIANT THERAPEUTICS, INC. | Disposition Stock Option (Right to Buy) | 124,000 | - | - | Direct |
1-10 of 18 transactions